Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 2013

View Archived Issues

Zebrafish model confirms novel gene involved in the regulation of thrombocyte formation

A non-invasive, diagnostic, and prognostic method to detect successful renal transplants

Confirmation of the efficacy of a small-molecule inhibitor against a protozoan parasitic infection

Targeting factor XII for anticoagulation tested with CSL-3F7

Fab demonstrates potential for reversing dabigatran-induced anticoagulation and bleeding

Prosensa receives E.U. FP7 research grant for development of DMD candidate

Aegerion obtains European approval for Lojuxta in HoFH

TechnoVax receives NIH grant to develop universal flu vaccine

Cancer Research Technology, Institute of Cancer Research and Merck Serono form alliance

La Jolla Institute extends collaboration with KKC

Teijin Pharma and Amgen to develop novel therapies for autoimmune diseases

Bionomics and Merck & Co. to develop candidates for chronic pain

Serina Therapeutics forms research agreement with the Scripps Research Institute

Polyphor and Boehringer Ingelheim advance macrocyclic drug discovery collaboration

NIH award supports Arisaph's development of small-molecule immune modulators

OncoGenex begins phase II trial evaluating OGX-427 in NSCLC

Pivotal trial of Exparel in intercostal nerve block does not meet primary endpoint

ImmunoGen gains IND clearance from FDA for novel EGFR-targeting antibody-drug conjugate

ViroPharma discontinues phase II trial of subcutaneous Cinryze combined with rHuPH20

Daiichi Sankyo updates developments of first quarter fiscal 2013

CovX Technologies patents novel monoclonal antibody conjugates

U.S. group discloses new miRNA-196a antagonists for cancer

FDA expands age indication for Menveo quadrivalent meningococcal vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...